Results 21 to 30 of about 4,423,584 (309)

Important Drop in Rate of Acute Diabetes Complications in People With Type 1 or Type 2 Diabetes After Initiation of Flash Glucose Monitoring in France: The RELIEF Study

open access: yesDiabetes Care, 2021
OBJECTIVE The RELIEF study assessed rates of hospitalization for acute diabetes complications in France before and after initiation of the FreeStyle Libre system.
R. Roussel   +7 more
semanticscholar   +1 more source

A Decade of Disparities in Diabetes Technology Use and HbA1c in Pediatric Type 1 Diabetes: A Transatlantic Comparison

open access: yesDiabetes Care, 2020
OBJECTIVE As diabetes technology use in youth increases worldwide, inequalities in access may exacerbate disparities in hemoglobin A1c (HbA1c). We hypothesized that an increasing gap in diabetes technology use by socioeconomic status (SES) would be ...
Ananta Addala   +9 more
semanticscholar   +1 more source

Type 1 Diabetes at a Crossroads! [PDF]

open access: yesDiabetes Care, 2015
“Be at a crossroads”: to be at a stage in your life when you have to make a very important decision (1). Type 1 diabetes at a crossroads? What does that really mean? It cannot mean that progress has not been made! Indeed, in the field of diabetes, reporting of new information is clearly outpacing our ability to incorporate new findings into clinical ...
William V. Tamborlane   +2 more
openaire   +3 more sources

Has COVID-19 Delayed the Diagnosis and Worsened the Presentation of Type 1 Diabetes in Children?

open access: yesDiabetes Care, 2020
OBJECTIVE To evaluate whether the diagnosis of pediatric type 1 diabetes or its acute complications changed during the early phase of the coronavirus disease 2019 (COVID-19) pandemic in Italy.
I. Rabbone   +4 more
semanticscholar   +1 more source

Type 1 Diabetes [PDF]

open access: yes, 2007
It is well known that type 1 diabetes is a chronic autoimmune disease in which the breakdown of normal tolerance to the cell allows the activation of T cell to multiple antigens. This induces a progressive destruction of cells and a state of chronic insulin deficiency.
Chiarelli, Francesco, Giannini, Cosimo
openaire   +3 more sources

Neutrophils in type 1 diabetes [PDF]

open access: yesJournal of Diabetes Investigation, 2016
AbstractType 1 diabetes is an autoimmune disease that afflicts millions of people worldwide. It occurs as the consequence of destruction of insulin‐producing pancreatic β‐cells triggered by genetic and environmental factors. The initiation and progression of the disease involves a complicated interaction between β‐cells and immune cells of both innate ...
Juan Huang   +3 more
openaire   +2 more sources

An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.

open access: yesNew England Journal of Medicine, 2019
BACKGROUND Type 1 diabetes is a chronic autoimmune disease that leads to destruction of insulin-producing beta cells and dependence on exogenous insulin for survival.
Herold Kc   +20 more
semanticscholar   +1 more source

Did the COVID-19 Lockdown Affect the Incidence of Pediatric Type 1 Diabetes in Germany?

open access: yesDiabetes Care, 2020
Psychological stress is a known general health risk potentially increasing the risk of type 1 diabetes. Consistent with this hypothesis, there were reports of a higher incidence of type 1 diabetes after other stressful catastrophic events, e.g., the ...
S. Tittel   +9 more
semanticscholar   +1 more source

Hypoglycemia in Type 1 Diabetes [PDF]

open access: yesDiabetes, 2010
In subjects with type 1 diabetes, autoimmune destruction of pancreatic β-cells leads eventually to an absolute requirement for insulin replacement therapy. Insulin delivered exogenously is not subject to normal physiological feedback regulation, so it may induce hypoglycemia even in the presence of an intact counterregulatory response.
McCrimmon, Rory J., Sherwin, Robert S.
openaire   +3 more sources

Home - About - Disclaimer - Privacy